Notice ID: e7eef74b44c64bb6a34cd240a14c7f8bAward NoticeAwarded
Diagnostic Test Development and Production for Emergency Response
Awarded on September 19, 2025. The description is published on SAM.gov: Full description on SAM.gov.
Awarded tounder 75D30125D20654 (source: SAM.gov award notice)• $148.0M
Description
No description in the SAM.gov data feed for this notice.
Overview
Agency:
Department of Health and Human ServicesCENTERS FOR DISEASE CONTROL AND PREVENTION
Office:CDC OFFICE OF ACQUISITION SERVICES
Posted:January 7, 2026
NAICS:541380: Testing Laboratories and Services
Last Updated:Aug 21, 2026
PSC:R499: SUPPORT- PROFESSIONAL: OTHER
Set-Aside:Not specified
Type:Award Notice
Place of Performance:Atlanta, Georgia, 30341
Award Date:Sep 19, 2025
Award Amount (SAM.gov award notice):$148.0M
Award Overview
Award Number
75D30125D20654
Award Amount (SAM.gov award notice)
$148.0M
Award Date
Sep 19, 2025
Awardee
Awardee UEI
KT4MLLHK99V6
Awardee CAGE Code
31101
Awardee Address
Manassas, VA 20110, UNITED STATES
Original Solicitation
Notice ID: e7eef74b44c64bb6a34cd240a14c7f8b
Posted Date: Jan 7, 2026
Original Response Deadline: Not specified
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
No documents available.
Lifecycle
Solicitation:
75D30125D20654- Awarded
This opportunity has been awarded.
- AwardedCurrentJan 7, 2026
Diagnostic Test Development and Production for Emergency Response
Similar Opportunities
Title | Phase | Agency | NAICS | Set Aside | Posted | Deadline | Location |
|---|---|---|---|---|---|---|---|
The vendor shall provide the license for the updated ABAQUS software. The vendor shall also provide technical support if/when needed throughout the year. If there are any issues with software the vendor shall provide fix. ABAQUS is approved in the CDC SRT tool. | Special Notice | 541380 | No Set-Aside | 06/25/2026 | 07/20/2027 | Atlanta, GA | |
The Centers for Disease Control and Prevention (CDC) awarded a sole source contract with MATHEMATICA INC., 1100 1ST ST NE FL 12, WASHINGTON, DC. 20002 This notice is provided in accordance with RFO FAR 8.401 & GSAM/R 538.7104-3(b)(1) . Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Division of Bacterial Diseases (DBD) requires support Services with the contractor listed above. The requested contractor Mathematica qualified as “innovator status” vendor for data analysis by Center for Medicare and Medicaid Services (CMS). Mathematica also has demonstrated experience and specialized staff with unique access and analytical capabilities for Medicaid data sets which captures the largest segment of US healthcare data, including births. The contractor shall perform analyses across four technical dimensions defined in the Statement of Work: (1) validating infant GBS case counts using TAF OT claims and evaluating a fourth case definition tied to maternal Medicaid IDs; (2) developing and refining a probabilistic mother-infant linkage algorithm using the Medicaid Case Number and supplementary variables; (3) estimating maternal vaccination coverage (COVID-19, influenza, Tdap, and prospectively RSV) accounting for bundled payment code effects; and (4) applying methods to reduce gestational age missingness using prenatal claims data. These tasks require continuity with linkage algorithms and case-definition logic Mathematica has already built and validated under prior CDC task orders. The authority permitting other than full and open competition is Title III of the Federal Property and Administrative Services Act of 1949 (41 U.S.C. 251, et seq.); Title 40 U.S.C. 501, Services for Executive Agencies, as implemented at FAR 8.401 and GSAM/R 538.7104-3(b)(1) "Only one source is capable of providing the products, services, or solution required at the level of quality required because the products, services, or solutions are unique or highly specialized." Through its prior contracts, Mathematica has already built key parts of this analysis—including updating the medical codes used to identify cases, working to link mother and infant records more completely, and adjusting for how individual states handle Medicaid enrollment for newborns. This steady, hands-on progress means Mathematica starts this next phase of work already ahead, with the knowledge and tools in place that a new contractor would not have. All responsible sources may submit a capability statement, proposal, or quotation to Robin C. Meyer, Contract Specialist, at rcm2@cdc.gov, which shall be considered by the agency. The deadline for submissions is Ocotber 31, 2026 at 4:30PM EST. The Government will review any/all information submitted to determine if other responsible sources exist that could provide this requirement. Information received in response to this announcement will be used solely for the purpose of determining whether to conduct a competitive procurement. | Special Notice | 541611 | No Set-Aside | 10/16/2026 | 10/31/2026 | - | |
PRESOLICITATION NOTICE Dose Reconstruction and Related Activities to Support NIOSH's Responsibilities under the Energy Employees Occupational Illness Compensation Act (EEOICPA) This presolicitation notice is prepared in accordance with Revolutionary FAR Overhaul 5.101. 1. Points of Contact H. Taylor Wellman, Contract Specialist Office of Acquisition Services Centers for Disease Control and Prevention Chamblee Campus Building 108 4770 Buford Highway Atlanta, GA 30341 Email: xur0@cdc.gov H. Dale Bish, Contracting Officer Office of Acquisition Services Centers for Disease Control and Prevention Chamblee Campus Building 108 4770 Buford Highway Atlanta, GA 30341 Email: uwo8@cdc.gov 2. Set-Asides This acquisition is currently unrestricted. All responsible sources, including small businesses and other than small business concerns, are encouraged to respond. 3. Codes for Services or Supplies North American Industry Classification System (NAICS) Code: 541990 – All Other Professional, Scientific, and Technical Services Product Service Code (PSC): R499 – Support-Professional: Other 4. Description (i) The Centers for Disease Control and Prevention (CDC), on behalf of the National Institute for Occupational Safety and Health (NIOSH), intends to solicit offers for Dose Reconstruction and Related Activities to Support NIOSH's Responsibilities under the Energy Employees Occupational Illness Compensation Act (EEOICPA). The anticipated contract will support NIOSH's Division of Compensation Analysis and Support (DCAS) in fulfilling its statutory obligations under EEOICPA by performing radiation dose reconstructions for claims referred by the Department of Labor (DOL) and evaluating petitions for additions of classes to the Special Exposure Cohort (SEC). The anticipated contract type is Cost Plus Award Fee (CPAF). The anticipated period of performance is March 1, 2027 through February 29, 2028 (base year), with four (4) twelve-month option periods through February 28, 2032. Work will be performed at the contractor's facility. The scope of work includes the following principal task areas: Identification of data relevant to reconstructing radiation doses and evaluating SEC petitions Claimant communications, including computer assisted telephone interviews Dose estimation and reporting Special Exposure Cohort petition evaluations Technical and program management support Operational continuity, cloud migration, and modernization of DCAS systems and processes Contractor personnel performing work under this contract will be required to obtain background investigations commensurate with a Level 5C Moderate Risk position sensitivity designation. Additionally, a reasonable number of contractor staff must possess or be able to obtain Department of Energy Q clearances to perform work under this contract. All contractor personnel must comply with applicable HHS and CDC information security policies. (ii) Not applicable. This acquisition is expected to exceed the simplified acquisition threshold. (iii) One or more of the items under this acquisition is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements. (iv) All technical data required to respond will be provided as part of the solicitation. (v) Not applicable. This is not a construction contract. (vi) All responsible sources may submit a quotation, bid, or proposal, as appropriate, which will be considered by the agency. (vii) Not applicable. This acquisition is competitive. (viii) Contractor personnel performing work under this contract will be required to obtain background investigations commensurate with a Level 5C Moderate Risk position sensitivity designation. Additionally, a reasonable number of contractor staff must possess or be able to obtain Department of Energy Q clearances. Additional information regarding security requirements will be provided as part of the solicitation. Timing There is no solicitation available at this time. A solicitation is anticipated to be issued in November 2026. | Pre-Solicitation | 541990 | No Set-Aside | 10/14/2026 | 10/30/2026 | Atlanta, GA | |
This presolicitation notice is prepared in accordance with Revolutionary FAR Overhaul 5.101. (1) Points of contact. H. Dale Bish: uwo8@cdc.gov; 404.498.1312 Henrietta Fumbah: ehu0@cdc.gov, 770.488.8239 (2) Set-asides. Small business set-asides are applicable by domain. Domain 1: 25% Small Business Set-Aside (Partial Small Business Set-Aside) Domain 2: 25% Small Business Set-Aside Aside (Partial Small Business Set-Aside) Domain 3: 25% Small Business Set-Aside Aside (Partial Small Business Set-Aside) Domain 4: 25% Small Business Set-Aside Aside (Partial Small Business Set-Aside) Domain 5: 100% Small Business Set-Aside (Total Small Business Set-Aside) (3) Codes for services or supplies. The following NAICS codes and size standards are anticipated: NAICS 541690 Other Scientific and Technical Consulting Services ($19M) NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (1,000 Employees) NAICS 611430 Professional and Management Development Training ($15M) (4) Description. (i) The Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Healthcare Quality Promotion (DHQP), announces its intent to compete a new Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract vehicle titled “Safety, Prevention, Epidemiology, and Education Development for Health Care and Antimicrobial Resistance (SPEED).” SPEED will provide CDC with an "as needed" mechanism to obtain healthcare epidemiology, health behavior, and healthcare-associated infection research support across five functional domains: (1) Domestic Antimicrobial Resistance, Infection Prevention and Control, and Adverse Events Services; (2) Healthcare Information Technology and Data Solutions Services; (3) Global Antimicrobial Resistance and Infection Prevention and Control Services; (4) Emergency Preparedness, Response Services, and Healthcare System Resilience Services; and (5) Workforce Training, Message Development, Dissemination, and Testing Services. The anticipated ordering period (period of performance) for the SPEED IDIQ is a 60-month period beginning on March 30, 2027 and ending March 29, 2032. Offerors may submit proposals to one or more domains and will be evaluated on technical approach including existing infrastructure and capacity, staffing approach, management approach, similar experience, price, and past performance. To ensure continuity of critical healthcare epidemiology and infection prevention research support with no lapse in service, DHQP extended the current Safe Healthcare, Epidemiology, Prevention Research Development (SHEPheRD) Program contracts through March 29, 2027, the day immediately preceding the SPEED anticipated effective start date. This extension allows CDC to maintain uninterrupted access to essential scientific, technical, and programmatic support while the SPEED solicitation, evaluation, and award process is completed. DHQP intends for SPEED to fully replace SHEPheRD upon award. CDC will provide further information regarding the solicitation timeline, evaluation criteria, and instructions for interested offerors in forthcoming notices. Interested parties are encouraged to monitor SAM.gov for the official solicitation and any applicable updates. SPEED shall consist of 5 Domains briefly described as follows: Domain 1: Domestic Antimicrobial Resistance, Infection Prevention and Control, and Adverse Events Services. The purpose of this domain is to obtain services that support the design, execution, and assessment of healthcare and community epidemiology research initiatives addressing antimicrobial resistance (AR), infection prevention and control (IPC), and adverse events domestically within U.S. healthcare settings and communities. These implementation services include developing and implementing study protocols, conducting clinical and epidemiologic investigations, evaluating outcomes, and translating research findings into scalable, evidence-based public health interventions. Domain 2: Healthcare Information Technology and Data Solutions Services The purpose of this domain is to obtain services for the development and deployment of digital health systems, advanced analytics, Artificial Intelligence (AI) and machine learning-driven tools, and mathematical modeling to strengthen surveillance, automate data processing, improve data quality, and enhance decision-making across health programs. This includes the ability of Offerors to develop, implement, or maintain healthcare or ancillary medical (e.g., laboratory, pharmacy, etc.) surveillance systems, deploy natural language processing applications and other artificial intelligence tools, conduct human factors engineering, and apply mathematical modeling to optimize system usability, workflow efficiency, and data interpretation Domain 3: Global Antimicrobial Resistance and Infection Prevention and Control Services The purpose of this domain is to obtain services for development and implementation of research projects and protocols focused on antimicrobial stewardship, antimicrobial resistance detection and control, global health coordination, surveillance, and prevention of healthcare-associated infections in global healthcare settings. These tasks include, but are not limited to, conducting program evaluations, clinical investigations, cost effectiveness and disease modeling analyses, and translating findings into scalable and sustainable public health interventions with a particular focus on low- and middle-income countries. Domain 4: Emergency Preparedness, Response Services, and Healthcare System Resilience Services The purpose of this domain is to obtain services to rapidly respond to healthcare quality and safety threats. Services that may be conducted under this domain include supporting CDC's ability to respond effectively and rapidly to outbreaks, emergencies, and public health threats during times of healthcare facility or health system stress or strain. Domain 5: Workforce Training, Message Development, Dissemination and Testing Services The purpose of this domain is to obtain services that strengthen the capacity, knowledge, and preparedness of healthcare workers, public health personnel (including CDC staff), and the general public to prevent infections and reduce the spread of antimicrobial resistance and other infectious disease threats. (ii) Applicable World Trade Organization Government Procurement Agreement (WTO GPA) and/or a Free Trade Agreement (FTA) (see Part 25) will be included at the task order level. The task order solicitation will include the appropriate terms and conditions. (iii) All technical data required to respond will be provided as part of the solicitation. (iv) All responsible sources may submit a quotation, bid, or proposal, as appropriate, which will be considered by the agency. (5) Timing. The solicitation is anticipated to be released by November 16, 2026. | Pre-Solicitation | 541690 | Partial Small Business Set-Aside | 10/08/2026 | 11/08/2026 | Atlanta, GA | |
| Awarded | 541330 | Service-Disabled Veteran-Owned Small Business Set-Aside | 09/25/2026 | Open | - |
Additional Details
Solicitation Number
75D30125D20654
Archive Date
Jan 8, 2026
Office Address
ATLANTA, GA, 30333